
Burzynski: The Cancer Cure Cover-Up
2016

Representation Score
Limited
2010
TV-GDirector
Eric Merola
Runtime
105 minutes
Average Rating
No ratings yetNew Showbiz Analysis
This documentary serves as a specialized biographical study rather than a vehicle for broad social representation. The narrative focuses on the legal and scientific conflicts between Dr. Stanislaw Burzynski and the FDA. Since the film centers on institutional litigation and clinical trials, it lacks the complexity found in broader social studies. The focus remains strictly on the tension between individual discovery and regulatory frameworks. Ultimately, the film's value lies in its portrayal of scientific defiance against established hierarchies rather than demographic variety.
Category Breakdown
The film focuses solely on medical litigation and biochemical research. There are no stories or explorations of LGBTQ+ identities or non-binary gender identities.
The story centers on Dr. Burzynski, a male figure in scientific authority. It does not show any challenges to traditional gender roles or diverse gender representations.
The protagonist's name hints at Central or Eastern European heritage. However, the film does not provide information about the racial makeup of the broader cast.
The film critiques Western institutional power by presenting legal battles as victories against systemic regulatory hurdles. It emphasizes individual empowerment over state-controlled medical oversight.
While the subject involves cancer treatment, the film does not feature characters with disabilities as active agents or explore neurodivergence.
Present on Screen
Limited or Absent
Official Synopsis
Burzynski, the Movie is the story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history. His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and could begin the final phase of FDA testing in 2011–barring the ability to raise the required $300 million to fund the final phase of FDA clinical trials.

2016

2011

2013

2013

2005

2019

2010

2004
No reviews yet. Be the first to share your thoughts on this movie!
Use the rating form above to leave a star rating and optional review.